These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 26935987)
1. Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. Wu J; Han J; Hou B; Deng C; Wu H; Shen L Oncol Rep; 2016 May; 35(5):2977-83. PubMed ID: 26935987 [TBL] [Abstract][Full Text] [Related]
2. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210 [TBL] [Abstract][Full Text] [Related]
3. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo. Yao S; Ye J; Yin M; Yu R Cancer Lett; 2020 Jul; 483():87-97. PubMed ID: 32268165 [TBL] [Abstract][Full Text] [Related]
4. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1. Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599 [TBL] [Abstract][Full Text] [Related]
5. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway. Wang L; Tian Z; Yang Q; Li H; Guan H; Shi B; Hou P; Ji M Oncotarget; 2015 Sep; 6(28):25917-31. PubMed ID: 26312762 [TBL] [Abstract][Full Text] [Related]
6. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3. Fan L; Zhu H; Tao W; Liu L; Shan X; Zhao M; Sun D Phytomedicine; 2019 Sep; 62():152931. PubMed ID: 31085375 [TBL] [Abstract][Full Text] [Related]
7. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma. Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036 [TBL] [Abstract][Full Text] [Related]
8. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway. Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938 [TBL] [Abstract][Full Text] [Related]
9. 4-Terpineol exhibits potent in vitro and in vivo anticancer effects in Hep-G2 hepatocellular carcinoma cells by suppressing cell migration and inducing apoptosis and sub-G1 cell cycle arrest. Liu S; Zhao Y; Cui HF; Cao CY; Zhang YB J BUON; 2016; 21(5):1195-1202. PubMed ID: 27837623 [TBL] [Abstract][Full Text] [Related]
10. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
11. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma. Modi SJ; Kulkarni VM Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846 [TBL] [Abstract][Full Text] [Related]
12. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression. Yin W; Xu J; Li C; Dai X; Wu T; Wen J Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594 [TBL] [Abstract][Full Text] [Related]
13. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells. Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870 [TBL] [Abstract][Full Text] [Related]
14. The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1. Xiong J; Yang H; Luo W; Shan E; Liu J; Zhang F; Xi T; Yang J Pharmacol Res; 2016 Mar; 105():121-33. PubMed ID: 26808085 [TBL] [Abstract][Full Text] [Related]
15. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1. Dai W; Wang F; He L; Lin C; Wu S; Chen P; Zhang Y; Shen M; Wu D; Wang C; Lu J; Zhou Y; Xu X; Xu L; Guo C Mol Carcinog; 2015 Apr; 54(4):301-11. PubMed ID: 24243709 [TBL] [Abstract][Full Text] [Related]
16. Extracts of Celastrus Orbiculatus Inhibit Cancer Metastasis by Down-regulating Epithelial-Mesenchymal Transition in Hypoxia-Induced Human Hepatocellular Carcinoma Cells. Qian YY; Shi YY; Lu SH; Yang T; Zhao XY; Yan Y; Li WY; Liu YQ Chin J Integr Med; 2019 May; 25(5):334-341. PubMed ID: 30046956 [TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling. Wang Y; Dong L; Li J; Luo M; Shang B Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366 [TBL] [Abstract][Full Text] [Related]
18. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Kim H; Kim EH; Eom YW; Kim WH; Kwon TK; Lee SJ; Choi KS Cancer Res; 2006 Feb; 66(3):1740-50. PubMed ID: 16452234 [TBL] [Abstract][Full Text] [Related]
19. Protopanaxadiol inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway. Yang L; Zhang XY; Li K; Li AP; Yang WD; Yang R; Wang P; Zhao ZH; Cui F; Qin Y; Yang JH; Tao HL; Sun T; Chen S; Yu PH; Liu HJ; Yang C Cell Death Dis; 2019 Aug; 10(9):630. PubMed ID: 31431619 [TBL] [Abstract][Full Text] [Related]
20. Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT. Wei Y; Lv B; Xie J; Zhang Y; Lin Y; Wang S; Zhong J; Chen Y; Peng Y; Ma J Drug Des Devel Ther; 2019; 13():2343-2355. PubMed ID: 31409969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]